CLSI Guidelines | 合法醫療器材資訊網

2020年3月26日 — Prior to 2020, CLSI recognized colistin breakpoints for Pseudomonas aeruginosa and Acinetobacter baumannii only, not for the Enterobacterales. Read More

Added historical CLSI polymyxin B MIC breakpoints for P. aeruginosa and Acinetobacter spp. 3 A Note on Terminology. As of January 2020, the term ... Read More

2020年1月26日 — Upcoming Presentation at ASM Microbe 2020, Chicago, IL ... Colistin and polymyxin B MIC breakpoints for Enterobacterales (formerly ECV). Read More

由 MJ Satlin 著作 · 2020 · 被引用 29 次 — Recent data on polymyxin pharmacokinetics, pharmacodynamics, toxicity, and clinical outcomes suggest these ... 2020 Dec 3;71(9):e523-e529. doi: 10.1093/cid​/ciaa121. ... Keywords: CLSI; EUCAST; clinical breakpoints; c Read More

2020年7月20日 — The 2020 CLSI Guidelines on Polymyxins have changed the MIC cutoffs, wherein it has removed sensitivity cutoff and just provides ... Read More

由 KL Chew 著作 · 2017 · 被引用 134 次 — with a susceptible breakpoint of ≤2 mg/liter and a resistant breakpoint of >2 mg/​liter (7). The Clinical and Laboratory Standards Institute (CLSI) has published ... Read More

由 Y Zhu 著作 · 2021 — The performance of Bio-kont to polymyxin B and colistin for ... according to the CLSI M100-E30 document (CLSI, 2020) and EUCAST clinical ... Read More

由 MJ Satlin 著作 · 2020 · 被引用 29 次 — 2020, CLSI revises colistin and polymyxin B breakpoints for P. aeruginosa and Acinetobacter spp. Publication of the first CLSI Enterobacterales colistin and ... Read More

2019年10月9日 — The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on ... prior to official approval of the meeting minutes at the January 2020 meeting. ... Previously, the CLSI had polymyxin B breakpoints for Pseudomonas ... Read More